Plasma exchange as a cost-effective option for treating Guillain-Barré syndrome.
作者信息
Buenz Eric J, Parry Gareth J, Ranta Annemarei
机构信息
Nelson Marlborough Institute of Technology, Nelson, New Zealand.
Nelson Marlborough Institute of Technology, 322 Hardy Street, Nelson, 7010, New Zealand, Capital & Coast District Health Board, Wellington, New Zealand.
出版信息
Ther Adv Neurol Disord. 2017 Jan;10(1):76-77. doi: 10.1177/1756285616659978. Epub 2016 Aug 16.
Abstract
摘要
相似文献
1
Plasma exchange as a cost-effective option for treating Guillain-Barré syndrome.
Ther Adv Neurol Disord. 2017 Jan;10(1):76-77. doi: 10.1177/1756285616659978. Epub 2016 Aug 16.
2
Treatment of Guillain-Barré syndrome: a cost-effectiveness analysis.
J Clin Apher. 1999;14(3):107-13. doi: 10.1002/(sici)1098-1101(1999)14:3<107::aid-jca1>3.0.co;2-3.
3
Cost-minimization analysis in the Indian subcontinent for treating Guillain Barre Syndrome patients with therapeutic plasma exchange as compared to intravenous immunoglobulin.
J Clin Apher. 2018 Dec;33(6):631-637. doi: 10.1002/jca.21646. Epub 2018 Oct 17.
4
Guillain-Barre syndrome in a 7-month-old boy successfully applied plasma exchange.
Transfus Apher Sci. 2016 Feb;54(1):139-43. doi: 10.1016/j.transci.2016.01.001. Epub 2016 Jan 12.
5
Plasma exchange for Guillain-Barré syndrome.
Cochrane Database Syst Rev. 2002(2):CD001798. doi: 10.1002/14651858.CD001798.
6
Plasma exchange for Guillain-Barré syndrome.
Cochrane Database Syst Rev. 2001(2):CD001798. doi: 10.1002/14651858.CD001798.
7
Cost analysis of plasma-exchange therapy for the treatment of Guillain-Barré syndrome. French Cooperative Group on Plasma Exchange in Guillain-Barré Syndrome.
Intensive Care Med. 2000 Aug;26(8):1094-100. doi: 10.1007/s001340051323.
8
A Novel Treatment Strategy for Severe Guillain-Barré Syndrome: Zipper Method.
J Child Neurol. 2019 Apr;34(5):277-283. doi: 10.1177/0883073819826225. Epub 2019 Jan 29.
9
Intravenous immunoglobulin for Guillain-Barré syndrome.
Cochrane Database Syst Rev. 2001(2):CD002063. doi: 10.1002/14651858.CD002063.
10
The acute phase reactant, fibrinogen, as a guide to plasma exchange therapy for acute Guillain-Barré syndrome.
J Clin Apher. 2006 Jul;21(2):105-10. doi: 10.1002/jca.20071.
引用本文的文献
1
Intravenous immunoglobulin and plasma exchange prescribing patterns for Guillain-Barre Syndrome in the United States-2001 to 2018.
Muscle Nerve. 2024 Dec;70(6):1192-1199. doi: 10.1002/mus.28265. Epub 2024 Sep 26.
本文引用的文献
1
A comparison between plasmapheresis and intravenous immunoglobulin in children with Guillain-Barré syndrome in Upper Egypt.
Ther Adv Neurol Disord. 2016 Jan;9(1):3-8. doi: 10.1177/1756285615610471.
2
Cost-minimization analysis comparing intravenous immunoglobulin with plasma exchange in the management of patients with myasthenia gravis.
Muscle Nerve. 2016 Jun;53(6):872-6. doi: 10.1002/mus.24960. Epub 2015 Nov 26.
3
Resource implications of a national health target: The New Zealand experience of a Shorter Stays in Emergency Departments target.
Emerg Med Australas. 2014 Dec;26(6):579-84. doi: 10.1111/1742-6723.12312. Epub 2014 Oct 23.
4
Intravenous immunoglobulin for Guillain-Barré syndrome.
Cochrane Database Syst Rev. 2014 Sep 19;2014(9):CD002063. doi: 10.1002/14651858.CD002063.pub6.
5
Comparison of intravenous immunoglobulin and plasma exchange in treatment of mechanically ventilated children with Guillain Barré syndrome: a randomized study.
Crit Care. 2011 Jul 11;15(4):R164. doi: 10.1186/cc10305.
6
Cost-minimization analysis of the direct costs of TPE and IVIg in the treatment of Guillain-Barré syndrome.
BMC Health Serv Res. 2011 May 16;11:101. doi: 10.1186/1472-6963-11-101.
7
Plasma exchange for Guillain-Barré syndrome.
Cochrane Database Syst Rev. 2001(2):CD001798. doi: 10.1002/14651858.CD001798.
Zotero 插件